Pharma IQ | 06/14/2010
Ensuring eCTD readiness is now critical for gaining first time market approval. Dr. Klaus Menges from the Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, Bfarm joins Pharma IQ to discuss strategies for successful eCTD lifecycle management.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More